10x Genomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
10x Genomics, Inc. (TXG) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 3.51 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-08-07
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2026-06-30 was 2.15M shares, a 22.78% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2026-03-31 was 1.36M shares, a 32.47% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-12-31 was 604.62K shares, a 25.40% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-09-30 was 778.19K shares, a 0.28% decline year-over-year.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2025 was 6.18M shares, a 44.01% increase from fiscal 2024.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2024 was 4.29M shares, a 85.05% increase from fiscal 2023.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 2.32M shares, a 61.71% decline from fiscal 2022.
- 10x Genomics, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 6.06M shares, a 524.77% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.15M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 3.51M shares 10-Q · filed 2026-08-07 | 4.12M shares derived: sum of 3 quarters · filed 2026-08-07 | 4.90M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 1.36M shares 10-Q · filed 2026-05-08 | 1.97M shares derived: sum of 2 quarters · filed 2026-05-08 | 2.74M shares derived: sum of 3 quarters · filed 2026-05-08 | 5.53M shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 604.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 1.38M shares derived: sum of 2 quarters · filed 2026-02-13 | 4.17M shares derived: sum of 3 quarters · filed 2026-02-13 | 6.18M shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 778.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 3.56M shares derived: sum of 2 quarters · filed 2025-11-07 | 5.58M shares 10-Q · filed 2025-11-07 | 6.39M shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | 2.79M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 4.80M shares 10-Q · filed 2025-08-08 | 5.61M shares derived: sum of 3 quarters · filed 2025-08-08 | 6.39M shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 2.02M shares 10-Q · filed 2025-05-09 | 2.83M shares derived: sum of 2 quarters · filed 2025-05-09 | 3.61M shares derived: sum of 3 quarters · filed 2025-05-09 | 5.32M shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 810.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 1.59M shares derived: sum of 2 quarters · filed 2025-02-13 | 3.30M shares derived: sum of 3 quarters · filed 2025-02-13 | 4.29M shares 10-K · filed 2025-02-13 |
| 2024-09-30 | 780.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | 2.49M shares derived: sum of 2 quarters · filed 2024-10-29 | 3.48M shares 10-Q · filed 2024-10-29 | 3.74M shares derived: sum of 4 quarters · filed 2024-10-29 |
| 2024-06-30 | 1.71M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 2.70M shares 10-Q · filed 2024-08-08 | 2.95M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.08M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 992.11K shares 10-Q · filed 2024-04-30 | 1.24M shares derived: sum of 2 quarters · filed 2024-04-30 | 1.36M shares derived: sum of 3 quarters · filed 2024-04-30 | 2.73M shares derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | 251.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 371.91K shares derived: sum of 2 quarters · filed 2024-02-15 | 1.74M shares derived: sum of 3 quarters · filed 2024-02-15 | 2.32M shares 10-K · filed 2024-02-15 |
| 2023-09-30 | 120.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 1.48M shares derived: sum of 2 quarters · filed 2023-11-03 | 2.07M shares 10-Q · filed 2023-11-03 | 2.67M shares derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | 1.36M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 1.95M shares 10-Q · filed 2023-08-04 | 2.55M shares derived: sum of 3 quarters · filed 2023-08-04 | 6.27M shares derived: sum of 4 quarters · filed 2023-08-04 |
| 2023-03-31 | 584.72K shares 10-Q · filed 2023-05-04 | 1.18M shares derived: sum of 2 quarters · filed 2023-05-04 | 4.91M shares derived: sum of 3 quarters · filed 2023-05-04 | 6.13M shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 597.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | 4.33M shares derived: sum of 2 quarters · filed 2023-02-16 | 5.54M shares derived: sum of 3 quarters · filed 2023-02-16 | 6.06M shares 10-K · filed 2023-02-16 |
| 2022-09-30 | 3.73M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 4.95M shares derived: sum of 2 quarters · filed 2022-11-03 | 5.46M shares 10-Q · filed 2022-11-03 | 5.60M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 1.22M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.73M shares 10-Q · filed 2022-08-09 | 1.88M shares derived: sum of 3 quarters · filed 2022-08-09 | 1.98M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 517.65K shares 10-Q · filed 2022-05-05 | 659.22K shares derived: sum of 2 quarters · filed 2022-05-05 | 761.66K shares derived: sum of 3 quarters · filed 2022-05-05 | 1.26M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 141.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | 244.01K shares derived: sum of 2 quarters · filed 2022-02-18 | 740.28K shares derived: sum of 3 quarters · filed 2022-02-18 | 970.03K shares 10-K · filed 2022-02-18 |
| 2021-09-30 | 102.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | 598.71K shares derived: sum of 2 quarters · filed 2021-11-05 | 828.46K shares 10-Q · filed 2021-11-05 | 919.65K shares derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | 496.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | 726.03K shares 10-Q · filed 2021-08-06 | 817.22K shares derived: sum of 3 quarters · filed 2021-08-06 | 943.49K shares derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | 229.75K shares 10-Q · filed 2021-05-07 | 320.94K shares derived: sum of 2 quarters · filed 2021-05-07 | 447.22K shares derived: sum of 3 quarters · filed 2021-05-07 | 1.13M shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-12-31 | 91.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 217.47K shares derived: sum of 2 quarters · filed 2021-02-26 | 904.80K shares derived: sum of 3 quarters · filed 2021-02-26 | 963.05K shares 10-K · filed 2021-02-26 |
| 2020-09-30 | 126.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 813.61K shares derived: sum of 2 quarters · filed 2020-11-12 | 871.86K shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 687.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 745.59K shares 10-Q · filed 2020-08-12 | ||
| 2020-03-31 | 58.25K shares 10-Q · filed 2020-05-12 |